CoChat

Mutations altering acetylated residues in the CTD of HIV-1 integrase cause defects in proviral transcription at early times after integration of viral DNA

Open access
Winans, Shelby, Goff, Stephen P. · 2020 · PLOS Pathogens

The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.

Abstract

The central function of the retroviral integrase protein (IN) is to catalyze the integration of viral DNA into the host genome to form the provirus. The IN protein has also been reported to play a role in a number of other processes throughout the retroviral life cycle such as reverse transcription, nuclear import and particle morphogenesis. Studies have shown that HIV-1 IN is subject to multiple post-translational modifications (PTMs) including acetylation, phosphorylation and SUMOylation. However, the importance of these modifications during infection has been contentious. In this study we attempt to clarify the role of acetylation of HIV-1 IN during the retroviral life cycle. We show that conservative mutation of the known acetylated lysine residues has only a modest effect on reverse transcription and proviral integration efficiency in vivo. However, we observe a large defect in successful expression of proviral genes at early times after infection by an acetylation-deficient IN mutant that cannot be explained by delayed integration dynamics. We demonstrate that the difference between the expression of proviruses integrated by an acetylation mutant and WT IN is likely not due to altered integration site distribution but rather directly due to a lower rate of transcription. Further, the effect of the IN mutation on proviral gene expression is independent of the Tat protein or the LTR promoter. At early times after integration when the transcription defect is observed, the LTRs of proviruses integrated by the mutant IN have altered histone modifications as well as reduced IN protein occupancy. Over time as the transcription defect in the mutant virus diminishes, histone modifications on the WT and mutant proviral LTRs reach comparable levels. These results highlight an unexpected role for the IN protein in regulating proviral transcription at early times post-integration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1009147

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Blocking acetylation of HIV-1 IN affects successful transduction of HeLa cells while causing only modest defects in early viral replication steps. Acetylation-site mutations were introduced into a pNL4.3R-E- luciferase reporter genome and used to prepare virus. HeLa cells were infected with fresh viral supernatant and collected at 48 hours post-infection. (A) Acetylation deficient mutant IN (QA) virus had major defect in successful viral transduction as measured by luciferase reporter readout. The K258R point mutation caused a significant 3-fold reduction in overall viral transduction. Other point mutations introduced in this region had no effect. Viral DNA intermediates were subsequently assayed using qPCR-based approaches. (B) Integrated provirus was quantified using an Alu-gag nested PCR approach and normalized to a housekeeping gene (GAPDH). Viruses carrying the K258R or QA mutant IN had a modest 2–3 fold defect in integration. (C) Products of reverse transcription (RT) were assayed by qPCR using LTR specific primers and normalized to GAPDH. Viruses carrying the K258R or QA mutant IN demonstrated an approximate 3-fold defect in reverse transcription. (D) 2-LTR circles, a dead end viral product that marks nuclear entry, were quantified using primers that span the LTR-LTR junction. No significant differences between WT and acetylation defective mutant viruses were observed. Data shown is average +/- SEs of a minimum of five independent experiments run in duplicate. Statistical significance was measured using a one-way ANOVA with Bonferroni correction for multiple comparisons, followed by a pairwise Welch’s t-test assuming unequal variance (* p < 0.01, **p<0.001, ***p<0.0001).
Fig 1 Blocking acetylation of HIV-1 IN affects successful transduction of HeLa cells while causing only modest defects in early viral replication steps. Acetylation-site mutations were introduced into a pNL4.3R-E- luciferase reporter genome and used to prepare virus. HeLa cells were infected with fresh viral supernatant and collected at 48 hours post-infection. (A) Acetylation deficient mutant IN (QA) virus had major defect in successful viral transduction as measured by luciferase reporter readout. The K258R point mutation caused a significant 3-fold reduction in overall viral transduction. Other point mutations introduced in this region had no effect. Viral DNA intermediates were subsequently assayed using qPCR-based approaches. (B) Integrated provirus was quantified using an Alu-gag nested PCR approach and normalized to a housekeeping gene (GAPDH). Viruses carrying the K258R or QA mutant IN had a modest 2–3 fold defect in integration. (C) Products of reverse transcription (RT) were assayed by qPCR using LTR specific primers and normalized to GAPDH. Viruses carrying the K258R or QA mutant IN demonstrated an approximate 3-fold defect in reverse transcription. (D) 2-LTR circles, a dead end viral product that marks nuclear entry, were quantified using primers that span the LTR-LTR junction. No significant differences between WT and acetylation defective mutant viruses were observed. Data shown is average +/- SEs of a minimum of five independent experiments run in duplicate. Statistical significance was measured using a one-way ANOVA with Bonferroni correction for multiple comparisons, followed by a pairwise Welch’s t-test assuming unequal variance (* p < 0.01, **p<0.001, ***p<0.0001).CC BY · PubMed Central
Fig 2 Proviruses integrated by an acetylation-deficient IN mutant (QA) exhibit significant reduction in viral gene transcription. (A) Steady-state viral mRNA levels were measured by qRT-PCR on total cellular RNA collected from infected HeLa cells at two days post-infection. Data shown are levels of viral mRNA as measured by primers amplifying spliced tat message. Detected viral RNA levels were normalized to viral DNA content to adjust for discrepancies in viral DNA available for transcription. Viral mRNA levels were significantly reduced from proviruses integrated by an acetylation deficient mutant IN (QA) (50 fold). Individual point mutations in IN had a more modest defect in viral mRNA levels ranging from 2-4-fold on average. Data shown are averages +/- SEs of three independent experiments run in duplicate. Statistical significance was assayed using a one-way ANOVA analysis. (B) Steady state viral mRNA levels produced from provirus integrated by the QA mutant IN vs. WT IN were measured using primers against various other viral transcripts and normalized to total viral DNA. Data is shown as a ratio of RNA levels detected from QA IN mutant virus vs. WT (C) Rate of transcription was measured using 5-ethynyl uridine (EU)-labeling of nascent transcripts followed by mRNA quantification using RT-qPCR with primers against various viral transcripts normalized to a housekeeping gene (GAPDH). Shown is the ratio in transcripts detected from proviruses integrated by a QA mutant IN vs. WT in a minimum of three independent experiments run in duplicate. All viral transcripts were reduced from proviruses integrated by the acetylation deficient mutant IN at high significance (80-fold average). Significance was measured using a paired t-test (* p < 0.01, **p<0.001, ***p<0.0001).
Fig 2 Proviruses integrated by an acetylation-deficient IN mutant (QA) exhibit significant reduction in viral gene transcription. (A) Steady-state viral mRNA levels were measured by qRT-PCR on total cellular RNA collected from infected HeLa cells at two days post-infection. Data shown are levels of viral mRNA as measured by primers amplifying spliced tat message. Detected viral RNA levels were normalized to viral DNA content to adjust for discrepancies in viral DNA available for transcription. Viral mRNA levels were significantly reduced from proviruses integrated by an acetylation deficient mutant IN (QA) (50 fold). Individual point mutations in IN had a more modest defect in viral mRNA levels ranging from 2-4-fold on average. Data shown are averages +/- SEs of three independent experiments run in duplicate. Statistical significance was assayed using a one-way ANOVA analysis. (B) Steady state viral mRNA levels produced from provirus integrated by the QA mutant IN vs. WT IN were measured using primers against various other viral transcripts and normalized to total viral DNA. Data is shown as a ratio of RNA levels detected from QA IN mutant virus vs. WT (C) Rate of transcription was measured using 5-ethynyl uridine (EU)-labeling of nascent transcripts followed by mRNA quantification using RT-qPCR with primers against various viral transcripts normalized to a housekeeping gene (GAPDH). Shown is the ratio in transcripts detected from proviruses integrated by a QA mutant IN vs. WT in a minimum of three independent experiments run in duplicate. All viral transcripts were reduced from proviruses integrated by the acetylation deficient mutant IN at high significance (80-fold average). Significance was measured using a paired t-test (* p < 0.01, **p<0.001, ***p<0.0001).CC BY · PubMed Central
Fig 3 Transcription from proviruses integrated by QA mutant IN is delayed relative to WT despite comparable integration timing. HeLa cells were infected with WT or QA mutant virus and DNA and RNA were collected at various time points ranging from 2 to 14 days. (A) Steady state viral mRNA levels were measured over the time course using qRT-PCR with primers targeting spliced tat message. Transcript levels were normalized to total viral DNA levels and the fold change in viral mRNA levels over time relative to the final time point (14 dpi) was quantified for WT and mutant viruses individually using the 2-ΔΔCt method and normalized to total viral DNA. Values are plotted on log scale to highlight the low value of the QA sample at early times. (B) Same data expressed as a ratio of detectable mRNA levels in cells infected by the QA mutant virus vs. WT virus at each time point. (C) Integrated proviral DNA was measured and quantified at the same time points using an Alu-gag based qPCR. The fold change in integrated provirus levels over time relative to the final time point (14 dpi) was quantified using the 2-ΔΔCt method and normalized to a housekeeping gene. (D) Same data expressed as a ratio of detectable proviral integrants in cells infected by the QA mutant virus vs. WT virus at each time point. Shown is the average +/- SEs from three independent biological replicates performed in duplicate. Statistical analysis of time course samples was assayed using a paired t-test comparing WT to QA mutant virus at individual time points (* p < 0.01).
Fig 3 Transcription from proviruses integrated by QA mutant IN is delayed relative to WT despite comparable integration timing. HeLa cells were infected with WT or QA mutant virus and DNA and RNA were collected at various time points ranging from 2 to 14 days. (A) Steady state viral mRNA levels were measured over the time course using qRT-PCR with primers targeting spliced tat message. Transcript levels were normalized to total viral DNA levels and the fold change in viral mRNA levels over time relative to the final time point (14 dpi) was quantified for WT and mutant viruses individually using the 2-ΔΔCt method and normalized to total viral DNA. Values are plotted on log scale to highlight the low value of the QA sample at early times. (B) Same data expressed as a ratio of detectable mRNA levels in cells infected by the QA mutant virus vs. WT virus at each time point. (C) Integrated proviral DNA was measured and quantified at the same time points using an Alu-gag based qPCR. The fold change in integrated provirus levels over time relative to the final time point (14 dpi) was quantified using the 2-ΔΔCt method and normalized to a housekeeping gene. (D) Same data expressed as a ratio of detectable proviral integrants in cells infected by the QA mutant virus vs. WT virus at each time point. Shown is the average +/- SEs from three independent biological replicates performed in duplicate. Statistical analysis of time course samples was assayed using a paired t-test comparing WT to QA mutant virus at individual time points (* p < 0.01).CC BY · PubMed Central
Fig 4 The effect of acetylation-deficient mutant IN on proviral transcription is independent of Tat and the LTR promoter. The QA mutation in the CTD of IN was introduced into pCMV-delta-R8.9 vector expressing only HIV-1 gag-pol. VSV-G psuedotyped virions were produced by co-transfecting the plasmid expressing WT or QA mutant gag-pol along with a minimal transducing ZsGreen reporter driven by a CMV promoter and a plasmid expressing the VSV-G envelope. HeLa cells were infected with these preparations and samples were collected two days post-infection. (A) ZsGreen expression profiles of infected cells. Representative flow cytometry data of one independent experiment is shown. (B) Average percent of ZsGreen positive cells and (C) mean fluorescence intensity (MFI) after infection with viruses carrying WT or QA mutant IN. Data shown are averages +/- SEs of four independent experiments run in duplicate. Statistical significance was gauged using a paired t-test comparing WT to QA mutant virus at individual time points (* p < 0.05, **p<0.01).
Fig 4 The effect of acetylation-deficient mutant IN on proviral transcription is independent of Tat and the LTR promoter. The QA mutation in the CTD of IN was introduced into pCMV-delta-R8.9 vector expressing only HIV-1 gag-pol. VSV-G psuedotyped virions were produced by co-transfecting the plasmid expressing WT or QA mutant gag-pol along with a minimal transducing ZsGreen reporter driven by a CMV promoter and a plasmid expressing the VSV-G envelope. HeLa cells were infected with these preparations and samples were collected two days post-infection. (A) ZsGreen expression profiles of infected cells. Representative flow cytometry data of one independent experiment is shown. (B) Average percent of ZsGreen positive cells and (C) mean fluorescence intensity (MFI) after infection with viruses carrying WT or QA mutant IN. Data shown are averages +/- SEs of four independent experiments run in duplicate. Statistical significance was gauged using a paired t-test comparing WT to QA mutant virus at individual time points (* p < 0.05, **p<0.01).CC BY · PubMed Central
Fig 5 Integration site distribution of proviruses integrated by either an acetylation deficient (QA) mutant or WT IN is similar. HeLa cells were infected with pNL4.3R-E- virus carrying either WT IN or the QA mutant IN and collected at two days post-infection. Genomic DNA was isolated from three independent biological replicates and used to construct next generation sequencing (NGS) libraries to map integration sites. Frequency of integration sites falling within annotated RefSeq genes (A), or within 1 kb of annotated CpG islands (B), or DNase hypersensitivity sites (C) was calculated using BedWindow. (D) Integration sites were compared to RNA polymerase II binding sites as determined from ENCODE ChIP-seq data. (E) Distance of each integration site to the nearest annotated transcription start site (TSS) was determined using BedClosest tool from BedTools suite. A 10 kb window around the TSS is shown. (F) Genomic coordinates of common histone modifications in HeLa cells were determined from ENCODE ChIP-seq data. Coordinates of “super enhancers” in HeLa cells were extracted from the SEA 3.0 database [71]. Frequency of integration within 1 kb of these locations was calculated. Frequency of integrations detected in a matched random control (MRC) data set for each analysis is shown as a dashed line. Data shown is average +/- SEs of three independent experiments. Statistical significance was assayed using a paired t-test (S2 Table). No significant differences in integration site distribution were detected between WT and mutant QA proviruses.
Fig 5 Integration site distribution of proviruses integrated by either an acetylation deficient (QA) mutant or WT IN is similar. HeLa cells were infected with pNL4.3R-E- virus carrying either WT IN or the QA mutant IN and collected at two days post-infection. Genomic DNA was isolated from three independent biological replicates and used to construct next generation sequencing (NGS) libraries to map integration sites. Frequency of integration sites falling within annotated RefSeq genes (A), or within 1 kb of annotated CpG islands (B), or DNase hypersensitivity sites (C) was calculated using BedWindow. (D) Integration sites were compared to RNA polymerase II binding sites as determined from ENCODE ChIP-seq data. (E) Distance of each integration site to the nearest annotated transcription start site (TSS) was determined using BedClosest tool from BedTools suite. A 10 kb window around the TSS is shown. (F) Genomic coordinates of common histone modifications in HeLa cells were determined from ENCODE ChIP-seq data. Coordinates of “super enhancers” in HeLa cells were extracted from the SEA 3.0 database [71]. Frequency of integration within 1 kb of these locations was calculated. Frequency of integrations detected in a matched random control (MRC) data set for each analysis is shown as a dashed line. Data shown is average +/- SEs of three independent experiments. Statistical significance was assayed using a paired t-test (S2 Table). No significant differences in integration site distribution were detected between WT and mutant QA proviruses.CC BY · PubMed Central
Fig 6 Proviruses integrated by QA mutant IN are less associated with an active chromatin mark, H3K27ac and with IN protein, than WT viruses. Viral DNAs associated with the active histone mark H3K27ac, with total histone H3, or with IN protein were quantified from infected HeLa cells via chromatin immunoprecipitation (ChIP) followed by qPCR using LTR specific primers. Data are shown as a percent relative to input DNA levels. (A) At two days post-infection, there was significantly less DNA of proviruses integrated by the QA mutant IN bound to H3K27ac as compared to WT control. In samples collected at five days post-infection from the same initial infections, quantities of viral DNA bound to H3K27ac for proviruses integrated by both WT and QA mutant IN reached comparable levels. Levels of viral DNAs associated with total histone H3 was comparable on mutant and WT LTRs at both time points. Data shown are the averages +/- SEs of three independent experiments run in duplicate. Statistical significance was gauged by unpaired t-test (* p < 0.01). (B) At 24 hours post-infection, significantly less viral DNA of the QA mutant was immunoprecipitated with antibody to IN. Raltegravir treatment during both WT and mutant virus infection resulted in significantly less viral DNA bound to IN at 24 hours post-infection. Similarly, a class I catalytic IN mutation (D64A) also results in less IN occupancy at the viral LTR. Statistical significance was gauged by unpaired t-test (* p < 0.01, **p<0.001). Results shown are averages +/- SEs of two independent experiments run in duplicate.
Fig 6 Proviruses integrated by QA mutant IN are less associated with an active chromatin mark, H3K27ac and with IN protein, than WT viruses. Viral DNAs associated with the active histone mark H3K27ac, with total histone H3, or with IN protein were quantified from infected HeLa cells via chromatin immunoprecipitation (ChIP) followed by qPCR using LTR specific primers. Data are shown as a percent relative to input DNA levels. (A) At two days post-infection, there was significantly less DNA of proviruses integrated by the QA mutant IN bound to H3K27ac as compared to WT control. In samples collected at five days post-infection from the same initial infections, quantities of viral DNA bound to H3K27ac for proviruses integrated by both WT and QA mutant IN reached comparable levels. Levels of viral DNAs associated with total histone H3 was comparable on mutant and WT LTRs at both time points. Data shown are the averages +/- SEs of three independent experiments run in duplicate. Statistical significance was gauged by unpaired t-test (* p < 0.01). (B) At 24 hours post-infection, significantly less viral DNA of the QA mutant was immunoprecipitated with antibody to IN. Raltegravir treatment during both WT and mutant virus infection resulted in significantly less viral DNA bound to IN at 24 hours post-infection. Similarly, a class I catalytic IN mutation (D64A) also results in less IN occupancy at the viral LTR. Statistical significance was gauged by unpaired t-test (* p < 0.01, **p<0.001). Results shown are averages +/- SEs of two independent experiments run in duplicate.CC BY · PubMed Central
Fig 7 Avian leukosis virus (ALV) has conserved lysine residues in CTD but transduction is unaffected by conservative mutation of these residues. (A) Schematic highlighting conserved lysine residues in the C-terminal domain of HIV-1 and ALV IN. (B) The six lysine residues in the CTD of ALV IN were conservatively mutated to arginine in the pRIAS single-round infection vector carrying a luciferase reporter (K6R). VSV-G pseudotyped virus was produced and subsequently used to infect chick embryonic fibroblast (CEF) cells. The K6R mutation had no effect on successful infection as measured by luciferase reporter readout. (C) Total viral DNA present in cells infected with virus carrying either the WT or K6R mutant IN was measured by qPCR using primers against luciferase and normalized to GAPDH. Data shown are the average +/- SEs of four independent experiments run in duplicate. Statistical significance was gauged by paired t-test (* p < 0.01).
Fig 7 Avian leukosis virus (ALV) has conserved lysine residues in CTD but transduction is unaffected by conservative mutation of these residues. (A) Schematic highlighting conserved lysine residues in the C-terminal domain of HIV-1 and ALV IN. (B) The six lysine residues in the CTD of ALV IN were conservatively mutated to arginine in the pRIAS single-round infection vector carrying a luciferase reporter (K6R). VSV-G pseudotyped virus was produced and subsequently used to infect chick embryonic fibroblast (CEF) cells. The K6R mutation had no effect on successful infection as measured by luciferase reporter readout. (C) Total viral DNA present in cells infected with virus carrying either the WT or K6R mutant IN was measured by qPCR using primers against luciferase and normalized to GAPDH. Data shown are the average +/- SEs of four independent experiments run in duplicate. Statistical significance was gauged by paired t-test (* p < 0.01).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. J Karn, 2000, Tat, a novel regulator of HIV transcription and latency, HIV Seq Compend, 2

Cited by

See all 29

Metadata

Authors
Winans, S., & Goff, S. P.
Affiliations
Howard Hughes Medical Institute (US)
Corresponding author
Goff, Stephen P.
Venue
PLOS Pathogens
Published
2020-12-22
Volume
16
Issue
12
Pages
e1009147
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W3114689305
Cited by
29
References
74
Citations by year
2026: 2 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 11 · 2021: 3
FWCI
2.35
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Cancer Institute (R01 CA 030488)
  • NIAID (F32 AI 149989)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
HIV-1 integrase, lysine acetylation, proviral transcription, post-translational modification, proviral integration, histone modifications, LTR promoter, retroviral life cycle
MeSH terms
Viral Transcription, Acetylation, Cell Line, DNA, Viral, Humans, Mutation, Protein Processing, Post-Translational, Proviruses, HIV-1, Virus Integration, HIV Integrase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.